CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- 4 Open-market sale Senior Vice President, Finance sold 1,581 shares at $4.86 ($7,684)
- 4 Open-market sale See Remarks sold 16,928 shares at $4.86 ($82,270)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Medical Officer sold 17,109 shares at $5.42 ($92,731)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Senior Vice President, Finance sold 896 shares at $6.35 ($5,690)
- 4 Open-market sale See Remarks sold 9,049 shares at $6.35 ($57,461)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Technology Officer sold 12,169 shares at $6.35 ($77,273)
- 4 Open-market sale Senior Vice President, Finance sold 7,722 shares at $6.70 ($51,737)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 5 of 20 · 383 filings